Skip to main content

Table 2 Effect of supplementation of soy aglycons of isoflavone on growth performance of Sprague-Dawley rats

From: Supplementary health benefits of soy aglycons of isoflavone by improvement of serum biochemical attributes, enhancement of liver antioxidative capacities and protection of vaginal epithelium of ovariectomized rats

Determinations

Rats with different treatments

Items

Sham

OVX

OVX/LSAI

OVX/HSAI

Average daily gain (g)

0.56 ± 0.16b

0.83 ± 0.23a

0.83 ± 0.20a

0.79 ± 0.21a

Average daily feed intake (g)

13.74 ± 0.70b

17.81 ± 0.98a

18.34 ± 1.08a

18. 43 ± 1.08a

Energy expenditure (kJ/d)

204.0 ± 10.4b

264.5 ± 14.6a

272.4 ± 16.0a

273.7 ± 16.0a

Feed/Gain

26.28 ± 3.33a

21.24 ± 1.70b

22.07 ± 3.80b

22.20 ± 3.46b

  1. a, bMeans (± SD, n = 10) in the same row with different superscripts differ significantly (P < 0.05). SAI: soy aglycons of isoflavone; Sham: negative control; OVX: overiectomized rats as positive control; OVX/LSAI: overiectomized rats with low level of SAI supplementation; OVX/HSAI: overiectomized rats with high level of SAI supplementation.